Literature DB >> 19345210

Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland.

Kaijin Wu1, Corrine Joffre, Xiaodong Li, Michelle MacVeigh-Aloni, Melinda Hom, Juliana Hwang, Chuanqing Ding, Stephane Gregoire, Lionel Bretillon, Jiang F Zhong, Sarah F Hamm-Alvarez.   

Abstract

Functional atrophy and accompanying lymphocytic infiltration and destruction of the lacrimal gland (LG) are characteristics of Sjögren's Syndrome (SjS). The male NOD mouse is an experimental model for the autoimmune exocrinopathy that develops in the LG of SjS patients. Acinar cells in LG of male NOD mice aged 3-4 months were previously shown to accumulate lipid droplets. In the current study, analysis of lipid components revealed that the accumulated lipids were mostly cholesteryl esters (CE). Gene expression microarray analysis followed by real-time RT-PCR revealed alterations in the expression of several genes involved in lipid homeostasis in LG of 12-week-old male NOD mice relative to matched BALB/c controls. A series of upregulated genes including apolipoprotein E, apolipoprotein F, hepatic lipase, phosphomevalonate kinase, ATP-binding cassette D1 and ATP-binding cassette G1 were identified. Comparison of liver mRNAs to LG mRNAs in BALB/c and NOD mice revealed that the differential expressions were LG-specific. Gene expression profiles were also characterized in LGs of female mice, younger mice and immune-incompetent NOD SCID mice. Investigation of the cellular distribution of Apo-E and Apo-F proteins suggested that these proteins normally coordinate to mediate lipid efflux from the acinar cells but that dysfunction of these processes due to missorting of Apo-F may contribute to CE deposition. Finally, the initiation and extent of lipid deposition were correlated with lymphocytic infiltration in the LG of male NOD mice. We propose that impaired lipid efflux contributes to lipid deposition, an event that may contribute to the development and/or progression of dacryoadenitis in the male NOD mouse.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19345210      PMCID: PMC2720431          DOI: 10.1016/j.exer.2009.03.020

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  66 in total

Review 1.  Current concepts on diagnosis, autoantibodies and therapy in Sjögren's syndrome.

Authors:  R Jonsson; H J Haga; T P Gordon
Journal:  Scand J Rheumatol       Date:  2000       Impact factor: 3.641

2.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

Authors:  Tomas Vaisar; Subramaniam Pennathur; Pattie S Green; Sina A Gharib; Andrew N Hoofnagle; Marian C Cheung; Jaeman Byun; Simona Vuletic; Sean Kassim; Pragya Singh; Helen Chea; Robert H Knopp; John Brunzell; Randolph Geary; Alan Chait; Xue-Qiao Zhao; Keith Elkon; Santica Marcovina; Paul Ridker; John F Oram; Jay W Heinecke
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

Review 3.  Growth factors in the tear film: role in tissue maintenance, wound healing, and ocular pathology.

Authors:  Bettina Klenkler; Heather Sheardown; Lyndon Jones
Journal:  Ocul Surf       Date:  2007-07       Impact factor: 5.033

4.  Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis.

Authors:  B T Sadatipour; J M Greer; M P Pender
Journal:  Ann Neurol       Date:  1998-12       Impact factor: 10.422

5.  Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans.

Authors:  Yu Wang; Karen S L Lam; Edward W Kraegen; Gary Sweeney; Jialiang Zhang; Annette W K Tso; Wing-Sun Chow; Nelson M S Wat; Jian Yu Xu; Ruby L C Hoo; Aimin Xu
Journal:  Clin Chem       Date:  2006-10-13       Impact factor: 8.327

6.  Deletion of the transmembrane transporter ABCG1 results in progressive pulmonary lipidosis.

Authors:  Angel Baldán; Paul Tarr; Charisse S Vales; Joy Frank; Thomas K Shimotake; Sam Hawgood; Peter A Edwards
Journal:  J Biol Chem       Date:  2006-08-03       Impact factor: 5.157

Review 7.  Autoimmune diseases and Sjogren's syndrome: an autoimmune exocrinopathy.

Authors:  Philip C Fox
Journal:  Ann N Y Acad Sci       Date:  2007-03-01       Impact factor: 5.691

8.  Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F.

Authors:  X Wang; D M Driscoll; R E Morton
Journal:  J Biol Chem       Date:  1999-01-15       Impact factor: 5.157

9.  Lipid transfer inhibitor protein (apolipoprotein F) concentration in normolipidemic and hyperlipidemic subjects.

Authors:  Richard E Morton; Hannah M Gnizak; Diane J Greene; Kyung-Hyun Cho; Victor M Paromov
Journal:  J Lipid Res       Date:  2007-09-27       Impact factor: 5.922

Review 10.  Inflammation and immune response in atherosclerosis.

Authors:  G K Hansson
Journal:  Curr Atheroscler Rep       Date:  1999-09       Impact factor: 5.967

View more
  13 in total

1.  Interferon gamma contributes to preimplantation embryonic development and to implantation site structure in NOD mice.

Authors:  A V C Seaward; S D Burke; B A Croy
Journal:  Hum Reprod       Date:  2010-09-02       Impact factor: 6.918

2.  Increased expression of cathepsins and obesity-induced proinflammatory cytokines in lacrimal glands of male NOD mouse.

Authors:  Xiaodong Li; Kaijin Wu; Maria Edman; Katja Schenke-Layland; Michelle MacVeigh-Aloni; Srikanth Reddy Janga; Barbara Schulz; Sarah F Hamm-Alvarez
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-12       Impact factor: 4.799

3.  A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome.

Authors:  Mihir Shah; Maria C Edman; Srikanth R Janga; Pu Shi; Jugal Dhandhukia; Siyu Liu; Stan G Louie; Kathleen Rodgers; J Andrew Mackay; Sarah F Hamm-Alvarez
Journal:  J Control Release       Date:  2013-07-25       Impact factor: 9.776

4.  NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis.

Authors:  Yaping Ju; Srikanth Reddy Janga; Wannita Klinngam; J Andrew MacKay; Dillon Hawley; Driss Zoukhri; Maria C Edman; Sarah F Hamm-Alvarez
Journal:  Exp Eye Res       Date:  2018-09-08       Impact factor: 3.467

5.  Imbalanced Rab3D versus Rab27 increases cathepsin S secretion from lacrimal acini in a mouse model of Sjögren's Syndrome.

Authors:  Zhen Meng; Maria C Edman; Pang-Yu Hsueh; Chiao-Yu Chen; Wannita Klinngam; Tanya Tolmachova; Curtis T Okamoto; Sarah F Hamm-Alvarez
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-13       Impact factor: 4.249

6.  The effects of apolipoprotein F deficiency on high density lipoprotein cholesterol metabolism in mice.

Authors:  William R Lagor; David W Fields; Sumeet A Khetarpal; Arthi Kumaravel; Wen Lin; Nathaniel Weintraub; Kaijin Wu; Sarah F Hamm-Alvarez; Denise Drazul-Schrader; Margarita de la Llera-Moya; George H Rothblat; Daniel J Rader
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

7.  Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.

Authors:  Mihir Shah; Maria C Edman; Srikanth Reddy Janga; Frances Yarber; Zhen Meng; Wannita Klinngam; Jonathan Bushman; Tao Ma; Siyu Liu; Stan Louie; Arjun Mehta; Chuanqing Ding; J Andrew MacKay; Sarah F Hamm-Alvarez
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-01-01       Impact factor: 4.799

8.  Sleep deprivation disrupts the lacrimal system and induces dry eye disease.

Authors:  Sanming Li; Ke Ning; Jing Zhou; Yuli Guo; Houjian Zhang; Yu Zhu; Liying Zhang; Changkai Jia; Yongxiong Chen; Peter Sol Reinach; Zuguo Liu; Wei Li
Journal:  Exp Mol Med       Date:  2018-03-02       Impact factor: 8.718

9.  Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.

Authors:  Zhen Meng; Wannita Klinngam; Maria C Edman; Sarah F Hamm-Alvarez
Journal:  PLoS One       Date:  2017-09-13       Impact factor: 3.240

10.  Increased Cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sjögren's Syndrome patients.

Authors:  Maria C Edman; Srikanth R Janga; Zhen Meng; Mercy Bechtold; Alexander F Chen; Chongiin Kim; Luke Naman; Arunava Sarma; Neha Teekappanavar; Alice Y Kim; Sara Madrigal; Simranjit Singh; Elizabeth Ortiz; Stratos Christianakis; Daniel G Arkfeld; Wendy J Mack; Martin Heur; William Stohl; Sarah F Hamm-Alvarez
Journal:  Sci Rep       Date:  2018-07-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.